Windlas Biotech Ltd. Statistics
Want to see IN:WINDLAS full AI Analyst Report?
Windlas Biotech Ltd. (WINDLAS) Stock Statistics & Valuation Metrics
Total Valuation
Windlas Biotech Ltd. has a market cap or net worth of INR 20.15B. The enterprise value is INR 21.04B.
- Market Cap
- INR 20.15B
- Enterprise Value
- INR 21.04B
Share Statistics
Windlas Biotech Ltd. has 20,636,229 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 20,636,229
- Owned by Insiders
- ―
- Owned by Institutions
- 0.23%
Financial Efficiency
Windlas Biotech Ltd.’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 9.13%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 9.13%
- Return on Capital Employed (ROCE)
- 0.13
- Revenue Per Employee
- 6.53M
- Profits Per Employee
- 479.83K
- Employee Count
- 1,385
- Asset Turnover
- 1.00
- Inventory Turnover
- 11.97
Valuation Ratios
The current PE Ratio of Windlas Biotech Ltd. is 31.25. Windlas Biotech Ltd.’s PEG ratio is -66.98.
- PE Ratio
- 31.25
- PS Ratio
- 2.10
- PB Ratio
- 3.63
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -66.98
Income Statement
In the last 12 months, Windlas Biotech Ltd. had revenue of 9.04B and earned 664.56M in profits. Earnings per share was 31.60.
- Revenue
- 9.04B
- Gross Profit
- 1.64B
- Operating Income
- 739.99M
- Pretax Income
- 869.77M
- Net Income
- 664.56M
- EBITDA
- 1.05B
- Earnings Per Share (EPS)
- 31.60
Cash Flow
In the last 12 months, operating cash flow was 559.24M and capital expenditures -293.90M, giving a free cash flow of 265.34M billion.
- Operating Cash Flow
- 559.24M
- Free Cash Flow
- 265.34M
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Windlas Biotech Ltd. pays an annual dividend of INR 6.30, resulting in a dividend yield of 0.63%
- Dividend Per Share
- INR 6.30
- Dividend Yield
- 0.63%
- Payout Ratio
- 19.93%
- Free Cash Flow Yield
- 1.29%
- Earnings Yield
- 3.23%
Stock Price Statistics
- Beta
- 0.98
- 52-Week Price Change
- 18.52%
- 50-Day Moving Average
- 1014.17
- 200-Day Moving Average
- 871.42
- Relative Strength Index (RSI)
- 57.76
- Average Volume (3m)
- 6,811
Important Dates
Windlas Biotech Ltd. upcoming earnings date is Feb 14, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Feb 14, 2027
- Ex-Dividend Date
- Jul 16, 2026
Financial Position
Windlas Biotech Ltd. as a current ratio of 1.95, with Debt / Equity ratio of 6.07%
- Current Ratio
- 1.95
- Quick Ratio
- 1.76
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 0.32
- Interest Coverage Ratio
- 15.33
Taxes
In the past 12 months, Windlas Biotech Ltd. has paid 205.21M in taxes.
- Income Tax
- 205.21M
- Effective Tax Rate
- 0.24
Enterprise Valuation
Windlas Biotech Ltd. EV to EBITDA ratio is 18.45, with an EV/FCF ratio of 79.70.
- EV to Sales
- 2.15
- EV to EBITDA
- 18.45
- EV to Free Cash Flow
- 79.70
- EV to Operating Cash Flow
- 37.81
Balance Sheet
Windlas Biotech Ltd. has INR 2.79B in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 2.79B billion.
- Cash & Marketable Securities
- INR 2.79B
- Total Debt
- INR 0.00
- Net Cash
- INR 2.79B
- Net Cash Per Share
- INR 135.11
- Tangible Book Value Per Share
- INR 281.47
Margins
Gross margin is 17.47%, with operating margin of 7.65%, and net profit margin of 6.78%.
- Gross Margin
- 17.47%
- Operating Margin
- 7.65%
- Pretax Margin
- 8.78%
- Net Profit Margin
- 6.78%
- EBITDA Margin
- 11.65%
- EBIT Margin
- 8.55%
Analyst Forecast
The average price target for Windlas Biotech Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 18.48%
- EPS Growth Forecast
- -0.41%
Scores
- Smart Score
- ―
- AI Score
- 65
